Don D. Sin

70.5k total citations · 11 hit papers
505 papers, 33.7k citations indexed

About

Don D. Sin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Don D. Sin has authored 505 papers receiving a total of 33.7k indexed citations (citations by other indexed papers that have themselves been cited), including 398 papers in Pulmonary and Respiratory Medicine, 166 papers in Physiology and 54 papers in Molecular Biology. Recurrent topics in Don D. Sin's work include Chronic Obstructive Pulmonary Disease (COPD) Research (315 papers), Asthma and respiratory diseases (140 papers) and Respiratory Support and Mechanisms (126 papers). Don D. Sin is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (315 papers), Asthma and respiratory diseases (140 papers) and Respiratory Support and Mechanisms (126 papers). Don D. Sin collaborates with scholars based in Canada, United States and Netherlands. Don D. Sin's co-authors include S. F. Paul Man, Àlvar Agustí, Leonardo M. Fabbri, Fernando J. Martínez, Jørgen Vestbo, Claus Vogelmeier, Antonio Anzueto, Robert A. Stockley, Peter J. Barnes and Masaharu Nishimura and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Don D. Sin

479 papers receiving 32.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

2012 9.4k citations Leonardo M. Fabbri, Don D. Sin et al. American Journal of Respiratory and Critical Care Medicine profile →
Why Are Patients With Chronic Obstructive Pulmonary Disease at Increased Risk of Cardiovascular Diseases?

2003 836 citations Don D. Sin et al. profile →
Risk Factors for Central and Obstructive Sleep Apnea in 450 Men And Women with Congestive Heart Failure

1999 833 citations Don D. Sin et al. American Journal of Respiratory and Critical Care Medicine profile →
Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease

2011 821 citations Harvey O. Coxson, Peter D. Paré et al. profile →
Mortality in COPD: role of comorbidities

2006 757 citations Don D. Sin, Joan B. Soriano et al. European Respiratory Journal profile →
The Relationship Between Reduced Lung Function and Cardiovascular Mortality

2005 680 citations Don D. Sin et al. CHEST Journal profile →
The Lung Tissue Microbiome in Chronic Obstructive Pulmonary Disease

2012 423 citations Don D. Sin, James C. Hogg et al. American Journal of Respiratory and Critical Care Medicine profile →
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision

2022 244 citations Leonardo M. Fabbri, Don D. Sin et al. American Journal of Respiratory and Critical Care Medicine profile →
Underdiagnosis and Overdiagnosis of Chronic Obstructive Pulmonary Disease

2018 203 citations Andrea S. Gershon, Don D. Sin et al. American Journal of Respiratory and Critical Care Medicine profile →
COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis

2021 171 citations Xuan Li, Anthony Raymond Tam et al. EClinicalMedicine profile →
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease

2024 34 citations Nathaniel M. Hawkins, Clémentine Nordon et al. profile →

Peers

Countries citing papers authored by Don D. Sin

Since Specialization

Citations

This map shows the geographic impact of Don D. Sin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don D. Sin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don D. Sin more than expected).

Fields of papers citing papers by Don D. Sin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don D. Sin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don D. Sin. The network helps show where Don D. Sin may publish in the future.

Co-authorship network of co-authors of Don D. Sin

This figure shows the co-authorship network connecting the top 25 collaborators of Don D. Sin. A scholar is included among the top collaborators of Don D. Sin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don D. Sin. Don D. Sin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Social Determinants of Health and Racial Disparities in Lung Function: Findings from the National Health and Nutrition Examination Survey, 2007–2012 2025 ·American Journal of Respiratory and Critical Care Medicine ·Amin Adibi, Christopher Carlsten, Emily Brigham, Don D. Sin, Peter Loewen, Mohsen Sadatsafavi	1
2	Healthcare resource utilisation in patients with exacerbations of COPD and associated cardiovascular events: the EXACOS-CV study 2025 ·ERJ Open Research ·Nathaniel M. Hawkins, (unknown), Clémentine Nordon, Manisha Talukdar, (unknown), John Paul Ekwaru, Tram Pham, Don D. Sin	0
3	Younger epigenetic age is associated with higher cardiorespiratory fitness in individuals with airflow limitation 2024 ·iScience ·Ana I. Hernández Cordero, Carli M. Peters, Xuan Li, Chen Xi Yang, Amirthagowri Ambalavanan, Julie L. MacIsaac, Michael S. Kobor, Gregory J. Fonseca, Dany Doiron, Wan C. Tan, Jean Bourbeau, Dennis Jensen, Don D. Sin, Graeme J. Koelwyn, Michael K. Stickland, Qing Duan, Janice M. Leung	3
4	Comparison between upper and lower airway microbiome profiles in chronic rhinosinusitis patients 2024 ·International Forum of Allergy & Rhinology ·(unknown), Changwan Ryu, (unknown), Judy Fan, (unknown), Rogério Pezato, Julia Yang, Don D. Sin, Andrew Thamboo	2
5	QRISK3 underestimates the risk of cardiovascular events in patients with COPD 2023 ·Thorax ·(unknown), Zhiwei Gao, Jennifer K Quint, Richard Russell, John R. Hurst, (unknown), Don D. Sin, Wenjia Chen, Mona Bafadhel, Mohsen Sadatsafavi	13
6	2023 Canadian Thoracic Society Guideline on Pharmacotherapy in Patients With Stable COPD 2023 ·CHEST Journal ·Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Shawn D. Aaron, Marie-France Beauchesne, (unknown), Anthony D’Urzo, Avtar Lal, François Maltais, (unknown), Sunita Mulpuru, Erika Penz, Don D. Sin, Anne Van Dam, Joshua Wald, Brandie Walker, Darcy D. Marciniuk	29
7	Quantifying COPD as a risk factor for cardiac disease in a primary prevention cohort 2023 ·European Respiratory Journal ·Laura C. Maclagan, Ruth Croxford, Anna Chu, Don D. Sin, Jacob A. Udell, Douglas S. Lee, Peter C. Austin, Andrea S. Gershon	32
8	Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties 2022 ·Vascular Pharmacology ·(unknown), Dmitri V. Pechkovsky, (unknown), (unknown), Zoe White, Ying Dong, Jessica Cait, Michael D. Hughes, Anthony Raymond Tam, (unknown), (unknown), Michael Walker, Kelly M. McNagny, Don D. Sin, Marco A. Ciufolini, Pascal Bernatchez	7
9	Vascular and renal telomere shortening in mice exposed to chronic intermittent hypoxia 2021 ·Canadian Journal of Physiology and Pharmacology ·Mohammad Badran, Bisher Abuyassin, Najib Ayas, Don D. Sin, Ismail Laher	7
10	The impact of lockdown timing on COVID-19 transmission across US counties 2021 ·EClinicalMedicine ·Xiaolin Huang, Xiaojian Shao, Li Xing, (unknown), Don D. Sin, Xuekui Zhang	31
11	Computed tomography total airway count predicts progression to COPD in at-risk smokers 2021 ·ERJ Open Research ·Miranda Kirby, Benjamin M. Smith, Naoya Tanabe, James C. Hogg, Harvey O. Coxson, Don D. Sin, Jean Bourbeau, Wan C. Tan	19
12	<p>Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples</p> 2019 ·International Journal of COPD ·Nawaf Alotaibi, Virginia Chen, Zsuzsanna Hollander, Jonathon Leipsic, Cameron Hague, Darra Murphy, Mari L. DeMarco, J. Mark FitzGerald, Bruce M. McManus, Raymond T. Ng, Don D. Sin	4
13	<p>Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada</p> 2019 ·International Journal of COPD ·Hamid Tavakoli, KATE JOHNSON, J Mark FitzGerald, Don D. Sin, Andrea S. Gershon, Tetyana Kendzerska, Mohsen Sadatsafavi	18
14	Excess economic burden of comorbidities in COPD: a 15-year population-based study 2017 ·European Respiratory Journal ·Wenjia Chen, J. Mark FitzGerald, Don D. Sin, Mohsen Sadatsafavi	45
15	Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study 2013 ·European Respiratory Journal ·Laura Labonté, (unknown), Wan C. Tan, Robert Cowie, Paul Hernandez, Kenneth R. Chapman, Pei Z. Li, Shawn D. Aaron, Andrea Benedetti, Mark Fitzgerald, François Maltais, Darcy D. Marciniuk, Denis E. O’Donnell, Don D. Sin, Jean Bourbeau	1
16	Molecular Signature of Smoking in Human Lung Tissues 2012 ·Cancer Research ·Yohan Bossé, Dirkje S. Postma, Don D. Sin, Maxime Lamontagne, Christian Couture, Nathalie Gaudreault, Philippe Joubert, Vivien W. Wong, Mark Elliott, Maarten van den Berge, Corry‐Anke Brandsma, Catherine Tribouley, Vladislav A. Malkov, Jeffrey A. Tsou, Gregory J. Opiteck, James C. Hogg, Andrew J. Sandford, Wim Timens, Peter D. Paré, Michel Laviolette	93
17	Incremental Value of Pulmonary Function and Sputum DNA Image Cytometry in Lung Cancer Risk Prediction 2011 ·Cancer Prevention Research ·Martin C. Tammemägi, Stephen Lam, Annette McWilliams, Don D. Sin	46
18	Epidural Analgesia Is Associated with Improved Health Outcomes of Surgical Patients with Chronic Obstructive Pulmonary Disease 2011 ·Anesthesiology ·Felix van Lier, Patrick J. van der Geest, Sanne E. Hoeks, Yvette R.B.M. van Gestel, (unknown), Don D. Sin, Robert Jan Stolker, Don Poldermans	63
19	Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection 2009 ·Journal of Clinical Oncology ·John Yee, Marianne D. Sadar, Don D. Sin, Michael A. Kuzyk, Li Xing, (unknown), Annette McWilliams, S. F. Paul Man, Stephen Lam	69
20	The pharmacoepidemiology of COPD: Recent advances and methodological discussion 2003 ·European Respiratory Journal ·Peter Burney, Samy Suissa, Joan B. Soriano, W M Vollmer, Giovanni Viegi, Sean D. Sullivan, Leonardo M. Fabbri, Don D. Sin, Pierre Ernst, David Coultas, Jean Bourbeau, Douglas W. Mapel, K Weiss, (unknown), David Price, Miriam Sturkenboom, R. Taylor, Gerry Hagan	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact